Sterility and Cross Contamination Challenges in Tissue Engineering and Regenerative Medicine

¡Advertencia! El contenido en esta página está disponible solo en los siguientes idiomas: Inglés - French

regenerative-medicine

Regenerative Medicine today is in wide expansion. With increasing research efforts in this field, commercial manufacturing aspects for bio-product are getting more attention.

From a GMP perspective, the most critical challenge due to specific factors characterizing cell manipulation is the asepsis of the process.

This paper also highlights other critical factors in the process to present a complete view of the risks connected with this activity.

A possible solution to these challenges is Isolation Technology, commonly used in the pharmaceutical industry and suggested by the regulatory guidelines in the field.

Read the full white paper – Download the pdf

Please send me further information

Fill in the form and we will contact you.

Open
 
 
 
I have read and understood the information sheet pursuant to Art. 13 GDPR.
I express my consent also for the processing of my personal data for profiling purposes and for the analysis of the preferences, interests and habits, as indicated in the section “Data processed and Purposes of processing” of the Privacy Policy published on the website.
 
 
COMECER NEWSLETTER SIGNUP 
I express my consent to process my personal data for marketing purposes and the sending of promotional and informative material, including newsletters and commercial communications concerning Comecer products/services, as indicated in the section “Data processed and Purposes of processing” of the Privacy Policy published on the website.
 
 
Please select your categories of interest:
 
 
 
 
 
Cancel

Necessary

Chiudi

Cancel

Statistics

Chiudi

Cancel

Targeting

Chiudi